Yung Zip Chemical Ind. Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 05, 2020 at 03:52 pm EDT
Share
Yung Zip Chemical Ind. Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 120.160 million compared to TWD 111.484 million a year ago. Operating income was TWD 9.545 million compared to TWD 10.452 million a year ago. Net income was TWD 9.595 million compared to TWD 11.959 million a year ago. Basic earnings per share was TWD 0.23 compared to TWD 0.28 a year ago. For the half year, sales was TWD 224.649 million compared to TWD 214.289 million a year ago. Operating income was TWD 23.363 million compared to TWD 17.352 million a year ago. Net income was TWD 26.933 million compared to TWD 19.024 million a year ago. Basic earnings per share was TWD 0.64 compared to TWD 0.45 a year ago.
YUNG ZIP CHEMICAL IND. CO., LTD. is a Taiwan-based company principally engaged in the manufacturing and trading of pharmaceutical ingredient products. Its diclofenac sodium (DCS) is used for the treatment of rheumatoid arthritis, bursitis and inflammation. The acyclovir (ACV) is used for the treatment of herpes virus infections. The miconazole nitrate (MCN) is used for the treatment of yeast infection. The sodium starch glycolate (SSG) is used as disintegrant in pharmaceutical preparation. The Clonidine hydrochloride (CLD) is used for the treatment of hypertension. The Company mainly distributes its products in domestic market and overseas markets, including the United States of America (the USA), Thailand, Indonesia and the Philippines.
YUNG ZIP CHEMICAL IND. CO., LTD. 
